RNA neoantigen vaccines prime long-lived CD8(+) T cells in pancreatic cancer. Sethna Z, Guasp P, Reiche C, Milighetti M, et al. Nature 2025 Feb 19. doi: 10.1038/s41586-024-08508.

Read + Share

Amedeo Smart

Independent Medical Education

Sethna Z, Guasp P, Reiche C, Milighetti M, et al. RNA neoantigen vaccines prime long-lived CD8(+) T cells in pancreatic cancer. Nature 2025 Feb 19. doi: 10.1038/s41586-024-08508.
PMID: 39972124